Pediatric Emergency Department, Istituto G, Gaslini, Genoa, Italy.
Clinical Pharmacology & Clinical Trials Unit, Istituto G, Gaslini, Genoa, Italy.
Ital J Pediatr. 2017 Dec 22;43(1):113. doi: 10.1186/s13052-017-0432-2.
Children are the most vulnerable population exposed to the use of antibiotics often incorrectly prescribed for the treatment of infections really due to viruses rather than to bacteria. We designed the MAREA study which consisted of two different studies: i) a surveillance study to monitor the safety/efficacy of the antibiotics for the treatment of pneumonia (CAP), pharyngotonsillitis and acute otitis media in children younger than 14 yrs old, living in Liguria, North-West Italy and ii) a pre-/post-interventional study to evaluate the appropriateness of antibiotic prescription for the treatment these infections. In this paper, we show only results of the appropriateness study about the antibiotic prescription for the treatment of pneumonia.
Patients included in this study met the following inclusion criteria: i) admission to the Emergency/Inpatient Dpt/outpatient clinic of primary care pediatricians for pneumonia requiring antibiotics, ii) informed written consent. The practice of prescribing antibiotics was evaluated before-and-after a 1 day-educational intervention on International/National recommendations.
Global adherence to guidelines was fulfilled in 45%: main reason for discordance was duration (shorter than recommended). Macrolide monotherapy and cephalosporins were highly prescribed; ampicillin/amoxicillin use was limited. 61% of patients received >1 antibiotic; parenteral route was used in 33%. After intervention, i) in all CAP, cephalosporin prescription decreased (-23%) and the inappropriate macrolide prescriptions was halved and, ii) in not hospitalized CAP (notH-CAP), macrolides were prescribed less frequently (-25%) and global adherence to guidelines improved (+39%); and iii) in H-CAP antibiotic choice appropriateness increase.
Prescribing practices were sufficiently appropriate but widespread preference for multidrug empirical regimens or macrolide in monotherapy deserve closer investigation.
儿童是最易受到抗生素滥用影响的人群,这些抗生素经常被错误地用于治疗实际上由病毒而非细菌引起的感染。我们设计了 MAREA 研究,该研究包括两项不同的研究:i)监测研究,以监测抗生素治疗 14 岁以下儿童肺炎(CAP)、咽扁桃体炎和急性中耳炎的安全性/疗效;ii)预/后干预研究,以评估这些感染抗生素处方的适宜性。在本文中,我们仅展示抗生素处方适宜性研究的结果,用于治疗肺炎。
符合以下纳入标准的患者纳入本研究:i)因肺炎需要抗生素而入住意大利西北部利古里亚地区急诊/住院部/初级保健儿科医生门诊;ii)知情书面同意。在对国际/国家建议进行为期 1 天的教育干预前后,评估抗生素处方的开具情况。
全球对指南的遵循率为 45%:不遵循的主要原因是疗程(短于推荐疗程)。大环内酯类单药治疗和头孢菌素类药物的处方率较高;青霉素/阿莫西林的使用受到限制。61%的患者接受了>1 种抗生素;33%的患者使用了静脉途径。干预后,i)所有 CAP 患者的头孢菌素处方减少(-23%),不适当的大环内酯类处方减少了一半,ii)非住院 CAP(非 H-CAP)中,大环内酯类药物的处方频率降低(-25%),指南遵循率提高(+39%);iii)H-CAP 中抗生素选择的适宜性增加。
处方实践足够适宜,但广泛偏好多药经验性治疗方案或大环内酯类单药治疗值得进一步调查。